Accelerator Corp.’s fourth fund expands to $62.8M for life science investment
The New York and Seattle-based Accelerator Corp. just expanded its fourth fund to $62.8 million to fund life sciences startups. The money comes from AbbVie, WuXi PharmaTech and Watson Fund.